NYSE:EBS
Emergent BioSolutions Inc.
- Stock
Last Close
8.91
30/08 20:00
Market Cap
487.34M
Beta: 0.93
Volume Today
9.83M
Avg: 1.88M
PE Ratio
−0.10
PFCF: −0.40
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 30.26M - | 36.74M 21.42% | 62.87M 71.12% | 51.78M 17.65% | 82.59M 59.52% | 62.70M 24.09% | 54.50M 13.08% | 305.10M 459.82% | 230.90M 24.32% | -223.80M 196.93% | -760.50M 239.81% | |
depreciation and amortization | 18.96M - | 32.45M 71.18% | 35.34M 8.88% | 38.23M 8.19% | 42.57M 11.36% | 62.20M 46.11% | 110.70M 77.97% | 114.50M 3.43% | 123.80M 8.12% | 143.30M 15.75% | 129.10M 9.91% | |
deferred income tax | 13.86M - | 16.49M 19.01% | 3.46M 79.00% | 5.19M 49.83% | 3.26M 37.21% | 8.60M 163.88% | -1.60M 118.60% | -2.40M 50% | 46.90M 2,054.17% | -19M 140.51% | -8.90M 53.16% | |
stock based compensation | 11.24M - | 12.83M 14.16% | 15.85M 23.53% | 18.48M 16.59% | 15.21M 17.67% | 23.20M 52.50% | 26.70M 15.09% | 51M 91.01% | 42.40M 16.86% | 45.10M 6.37% | 23.10M 48.78% | |
change in working capital | 24.14M - | 13.54M 43.91% | -65.90M 586.70% | -45.45M 31.04% | 53.72M 218.20% | -119.10M 321.69% | -39.90M 66.50% | 8.80M 122.06% | -156.40M 1,877.27% | 500K 100.32% | -70.30M 14,160% | |
accounts receivables | 35.46M - | 21.41M 39.63% | -64.35M 400.64% | -22.45M 65.12% | -4.81M 78.57% | -94.20M 1,858.42% | -8.20M 91.30% | 49M 697.56% | -48.20M 198.37% | 114.70M 337.97% | -21.60M 118.83% | |
inventory | 518K - | 4.23M 716.41% | -11.26M 366.30% | -9.03M 19.85% | 6.07M 167.21% | -1.90M 131.32% | -16.70M 778.95% | -83.20M 398.20% | -44M 47.12% | -51.90M 17.95% | 600K 101.16% | |
accounts payables | -551K - | -9.28M 1,584.03% | 4.75M 151.18% | -14.79M 411.46% | 16.13M 209.08% | -7M 143.39% | 16.50M 335.71% | 19.80M 20% | -2.50M 112.63% | -14M 460.00% | 10.60M 175.71% | |
other working capital | -11.28M - | -2.81M 75.05% | 4.96M 276.26% | 813K 83.61% | 36.33M 4,369.13% | -16M 144.04% | -31.50M 96.88% | 23.20M 173.65% | -61.70M 365.95% | -48.30M 21.72% | -59.90M 24.02% | |
other non cash items | -1.49M - | 261K 117.54% | -7.15M 2,841.00% | -14.73M 105.97% | 10.78M 173.14% | 4.20M 61.03% | 37.60M 795.24% | 59M 56.91% | 33.50M 43.22% | 19.80M 40.90% | 481.20M 2,330.30% | |
net cash provided by operating activities | 96.97M - | 112.32M 15.83% | 44.46M 60.42% | 53.49M 20.31% | 208.14M 289.14% | 41.80M 79.92% | 188M 349.76% | 536M 185.11% | 321.10M 40.09% | -34.10M 110.62% | -206.30M 504.99% | |
investments in property plant and equipment | -42.02M - | -30.67M 27.01% | -44.81M 46.10% | -76.26M 70.17% | -54.83M 28.10% | -72.10M 31.50% | -86.90M 20.53% | -141M 62.26% | -225M 59.57% | -115.80M 48.53% | -51.60M 55.44% | |
acquisitions net | -25.87M - | -179.38M 593.31% | -650K 99.64% | -827.70M - | 270.20M - | |||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | -195.10M - | 2.60M 101.33% | -10M 484.62% | -10M 0% | -265.50M - | -6.30M 97.63% | ||||||
net cash used for investing activites | -67.89M - | -210.05M 209.38% | -45.46M 78.36% | -76.26M 67.74% | -249.93M 227.75% | -897.20M 258.98% | -96.90M 89.20% | -151M 55.83% | -225M 49.01% | -381.30M 69.47% | 212.30M 155.68% | |
debt repayment | -62.77M - | -62M 1.23% | -20M - | -2.80M 86% | -116.30M 4,053.57% | -387.10M 232.85% | -35.90M 90.73% | -33.80M 5.85% | -543.40M 1,507.69% | |||
common stock issued | 8.20M - | 31.60M 285.37% | 15.90M 49.68% | 5M 68.55% | 10.20M 104% | |||||||
common stock repurchased | -213K - | -200K 6.10% | -100K 50% | -33.08M - | -100K 99.70% | -7.40M 7,300% | -13.80M 86.49% | -106M 668.12% | -82.10M 22.55% | |||
dividends paid | -800.00K - | -17.80M 2,125.00% | -15.90M 10.67% | -5M 68.55% | ||||||||
other financing activites | 71.60M - | 261.07M 264.63% | 33.55M 87.15% | -18.64M 155.56% | 1.68M 108.99% | 791.60M 47,131.50% | 80.40M 89.84% | 456.60M 467.91% | 900K 99.80% | 597.10M 66,244.44% | -2.50M 100.42% | |
net cash used provided by financing activities | 8.61M - | 198.87M 2,209.27% | 33.45M 83.18% | -18.64M 155.73% | -51.40M 175.74% | 788.70M 1,634.41% | -35.90M 104.55% | 69.50M 293.59% | -141M 302.88% | 481.20M 441.28% | -535.70M 211.33% | |
effect of forex changes on cash | -14K - | 21K 250% | -150K 814.29% | 129K 186% | -27K 120.93% | -200K 640.74% | 400K 300% | -1M 350% | -300K 70% | 500K 266.67% | -1.20M 340% | |
net change in cash | 37.67M - | 101.16M 168.53% | 32.30M 68.07% | -41.28M 227.82% | -93.22M 125.82% | -66.90M 28.24% | 55.60M 183.11% | 453.50M 715.65% | -45.20M 109.97% | 66.30M 246.68% | -530.90M 900.75% | |
cash at beginning of period | 141.67M - | 179.34M 26.59% | 280.50M 56.41% | 312.80M 11.51% | 271.51M 13.20% | 179.30M 33.96% | 112.40M 37.31% | 168M 49.47% | 621.50M 269.94% | 576.30M 7.27% | 642.60M 11.50% | |
cash at end of period | 179.34M - | 280.50M 56.41% | 312.80M 11.51% | 271.51M 13.20% | 178.29M 34.33% | 112.40M 36.96% | 168M 49.47% | 621.50M 269.94% | 576.30M 7.27% | 642.60M 11.50% | 111.70M 82.62% | |
operating cash flow | 96.97M - | 112.32M 15.83% | 44.46M 60.42% | 53.49M 20.31% | 208.14M 289.14% | 41.80M 79.92% | 188M 349.76% | 536M 185.11% | 321.10M 40.09% | -34.10M 110.62% | -206.30M 504.99% | |
capital expenditure | -42.02M - | -30.67M 27.01% | -44.81M 46.10% | -76.26M 70.17% | -54.83M 28.10% | -72.10M 31.50% | -86.90M 20.53% | -141M 62.26% | -225M 59.57% | -115.80M 48.53% | -51.60M 55.44% | |
free cash flow | 54.95M - | 81.64M 48.59% | -353K 100.43% | -22.77M 6,350.42% | 153.31M 773.30% | -30.30M 119.76% | 101.10M 433.66% | 395M 290.70% | 96.10M 75.67% | -149.90M 255.98% | -257.90M 72.05% |
All numbers in USD (except ratios and percentages)